MATN Mateon Therapeutics Inc
- 0.000
- 0.0000.00%
Mateon Therapeutics Inc News
Mateon Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities
Mateon Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities
Mateon Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities
Mateon Therapeutics Inc | D: Filing D
Mateon Therapeutics Inc | 3: Initial statement of beneficial ownership of securities
Mateon Therapeutics Inc | 3: Initial statement of beneficial ownership of securities
Mateon Therapeutics Inc | 4: Statement of changes in beneficial ownership of securities
Mateon Therapeutics Inc | 3: Initial statement of beneficial ownership of securities
Mateon Therapeutics Inc | D: Filing D
Mateon Therapeutics Inc | D: Filing D
Mateon Therapeutics Inc | 3: Initial statement of beneficial ownership of securities
Mateon Therapeutics Inc | 3: Initial statement of beneficial ownership of securities
Mateon Therapeutics Inc | 3: Initial statement of beneficial ownership of securities
Mateon Therapeutics Inc | 3: Initial statement of beneficial ownership of securities
Mateon Therapeutics Inc | 3: Initial statement of beneficial ownership of securities
Mateon Therapeutics Inc | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Mateon Therapeutics Inc | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Mateon Therapeutics Inc | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Mateon Therapeutics Inc | SC 13D: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities
Mateon Therapeutics Inc | SC 13G/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities by passive investors and certain institutions (Amendment)
Analysis
Price Target
No Data
No Data